Actionnariat et activité des initiés pour Moleculin Biotech, Inc. (MBRX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.74 |
| Capitalisation | $4M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.0M | $7.7M | $7.1M | $10.7M | $15.2M | $70.9M | $43.1M | $23.6M | $4.3M | $8.9M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | 0 | $56000 | $11000 | $1000 | $45000 | 0 | 0 | 0 | $7000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $5.2M | $8.3M | $8.0M | $13.5M | $17.2M | $72.5M | $45.6M | $26.3M | $5.2M | $9.7M |
| Immobilisations Corporelles | $23128 | $33000 | $463000 | $603000 | $685000 | $445000 | $678000 | $796000 | $583000 | $314000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M | $11.1M |
| Actifs Totaux | $16.4M | $19.5M | $19.6M | $25.2M | $29.2M | $84.1M | $57.4M | $38.2M | $16.9M | $22.1M |
| Dettes Fournisseurs | $399000 | $810000 | $1.2M | $2.2M | $1.1M | $1.4M | $2.1M | $2.5M | $2.0M | $3.5M |
| Dette à Court Terme | $296000 | 0 | 0 | $103000 | $118000 | $96000 | 0 | 0 | 0 | $137000 |
| Passifs Courants | $1.3M | $2.2M | $3.9M | $3.6M | $2.9M | $3.6M | $4.8M | $6.8M | $5.4M | $6.9M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $1.4M | $2.4M | $5.3M | $9.7M | $11.3M | $5.1M | $5.2M | $12.1M | $10.9M | $7.1M |
| Réserves | -$4.7M | -$14.5M | -$26.4M | -$39.6M | -$56.9M | -$72.8M | -$101.8M | -$131.6M | -$153.4M | -$206.0M |
| Capitaux Propres | $15.0M | $17.1M | $14.3M | $15.6M | $17.9M | $79.0M | $52.2M | $26.1M | $6.0M | $15.0M |
| Dette Totale | $296412 | 0 | 0 | $379000 | $277000 | $159000 | $451000 | $574000 | $478000 | $359000 |
| Dette Nette | -$4.7M | -$7.7M | -$7.1M | -$10.4M | -$14.9M | -$70.7M | -$42.7M | -$23.0M | -$3.8M | -$8.5M |
| Fonds de Roulement | $3.9M | $6.1M | $4.1M | $9.9M | $14.3M | $68.9M | $40.8M | $19.5M | -$165000 | $2.8M |
Santé financière
| Dette / Capitaux propres | 0.03 |
| Ratio de liquidité | 0.94 |
Rentabilité
| Rentabilité des capitaux propres | -816.56% |
| Rentabilité du capital investi | -242.25% |
| Rentabilité des actifs | -143.82% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ADAP · AIMD · APLM · ATHA · BLRX · CTXR · ICU
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de MBRX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions